Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Q: How many shares did Recursion (RXRX) grant as inducement RSUs on February 6, 2026?

Recursion granted 820,431 RSUs to new employees as inducements. According to the company, the awards were granted to 17 new employees under the 2024 Inducement Equity Incentive Plan and recorded on February 6, 2026.

Q: Why did Recursion (RXRX) grant inducement RSUs under the 2024 Plan on February 6, 2026?

The grants were made as inducement awards to support new hires' commencement of employment. According to the company, awards were approved under Nasdaq Listing Rule 5635(c)(4) as material inducements tied to hiring.

Recursion (NASDAQ: RXRX) announced that on February 6, 2026 its Compensation Committee approved inducement restricted stock unit awards covering 820,431 shares of Class A common stock granted to 17 new employees under the 2024 Inducement Equity Incentive Plan.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Very Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Recursion (NASDAQ: RXRX) announced that on February 6, 2026 its Compensation Committee approved inducement restricted stock unit awards covering 820,431 shares of Class A common stock granted to 17 new employees under the 2024 Inducement Equity Incentive Plan.

Each RSU vests 25% at the first quarterly vesting date on or after the one-year anniversary of the vesting commencement date, then vests at 1/16th each quarter thereafter, subject to continued employment and plan/grant agreement terms. Grants were made pursuant to Nasdaq Listing Rule 5635(c)(4).

Argus Feb 12 session

-3.50% close to close Open Argus

Details

News Market Reaction – RXRX

On Feb 12, the day this news came out, RXRX closed 3.50% below the previous close.

Data tracked by StockTitan Argus for the Feb 12 session.

Key Figures

Inducement RSUs granted: 820,431 shares Employees receiving awards: 17 employees Initial vesting tranche: 25% of shares +5 more

Inducement RSUs granted: 820,431 shares; Aggregate RSU awards to new employees under 2024 Inducement Plan
Employees receiving awards: 17 employees; New hires granted inducement RSUs
Initial vesting tranche: 25% of shares; Vests on first quarterly date after one-year anniversary
Subsequent vesting rate: 1/16th per quarter; Quarterly vesting after first anniversary tranche until fully vested
Vesting condition: Continued employment; RSU vesting contingent on ongoing employment
Plan name: 2024 Inducement Equity Incentive Plan; Governs these inducement RSU awards
Price vs 52-week high: -69.98%; Current price vs 52-week high of $12.36 pre-announcement
Price change pre-news: -3.64%; 24h move in RXRX before inducement RSU news

Historical Context

5 past events · Latest: Jan 06

5 events

Jan 06
Conference participation

24h Move

+4.1%

J.P. Morgan and Needham conference appearances announced with webcast access.
Dec 08
Clinical data update

24h Move

+2.3%

Positive Phase 1b/2 REC-4881 TUPELO results in FAP with durable responses.
Dec 01
Webinar announcement

24h Move

-5.8%

Scheduled webinar for upcoming TUPELO REC-4881 clinical data readout.
Nov 05
Earnings and update

24h Move

-0.8%

Q3 2025 results with lower revenue, high R&D spend, and net loss disclosed.
Nov 05
Leadership transition

24h Move

-0.8%

CEO transition plan outlining Najat Khan as new CEO and governance changes.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

restricted stock unit (rsu), nasdaq listing rule 5635(c)(4), inducement equity incentive plan

3 terms

restricted stock unit (rsu) financial

"approved the grant of inducement restricted stock unit (RSU) awards covering 820,431 shares"

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

nasdaq listing rule 5635(c)(4) regulatory

"pursuant to Nasdaq Listing Rule 5635(c)(4). Each inducement RSU award will vest"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

inducement equity incentive plan financial

"new employees under Recursion's 2024 Inducement Equity Incentive Plan (the “2024 Plan”)"

An inducement equity incentive plan is a program that grants employees or executives company shares or stock options to motivate and reward their work, often as a way to attract new talent. It aligns their interests with the company's success, encouraging them to contribute to long-term growth. For investors, such plans can influence a company's stock performance and overall financial health by motivating key personnel.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

02/12/2026 - 07:59 AM

Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 820,431 shares of its class A common stock in the aggregate to 17 new employees under Recursion's 2024 Inducement Equity Incentive Plan (the “2024 Plan”). Each award was granted as an inducement material to the employee's commencement of employment with Recursion, or a subsidiary of Recursion, pursuant to Nasdaq Listing Rule 5635(c)(4).

Each inducement RSU award will vest as to 25% of the shares subject to the award on the first quarterly vesting date on or following the one-year anniversary of the vesting commencement date, and as to 1/16th of the shares on each quarterly vesting date thereafter until the inducement RSU award is fully vested, subject to the inducement RSU award recipient’s continued employment through the company vesting dates. Each inducement RSU award is subject to the terms and conditions of the 2024 Plan and the grant agreements covering the awards.

About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.recursion.com, or connect on X and LinkedIn.

Media Contact
media@recursion.com

Investor Contact
investor@recursion.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Recursion (RXRX) grant as inducement RSUs on February 6, 2026?

Recursion granted 820,431 RSUs to new employees as inducements. According to the company, the awards were granted to 17 new employees under the 2024 Inducement Equity Incentive Plan and recorded on February 6, 2026.

What is the vesting schedule for the RXRX inducement RSU awards granted February 6, 2026?

The RSUs vest 25% at the first quarterly vesting date on or after the one-year anniversary. According to the company, the remaining shares vest at 1/16th per quarter thereafter, subject to continued employment and plan terms.

Why did Recursion (RXRX) grant inducement RSUs under the 2024 Plan on February 6, 2026?

The grants were made as inducement awards to support new hires' commencement of employment. According to the company, awards were approved under Nasdaq Listing Rule 5635(c)(4) as material inducements tied to hiring.

How many employees received inducement RSU awards from Recursion (RXRX) in this grant?

Seventeen new employees received inducement RSU awards in this grant. According to the company, the aggregate award covers 820,431 shares and each grant is governed by the 2024 Plan and individual grant agreements.

Are Recursion's (RXRX) inducement RSU awards subject to continued employment and plan terms?

Yes. The awards vest only if recipients remain employed through scheduled vesting dates. According to the company, each inducement RSU is subject to the 2024 Plan and the specific grant agreement terms.

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules